Share Buyback Programme

RNS Number : 3599B
British American Tobacco PLC
11 February 2022
 

British American Tobacco p.l.c.

 

11 February 2022

SHARE BUYBACK PROGRAMME

British American Tobacco p.l.c. (the "Company") has today announced a programme to buyback up to £2 billion of BAT ordinary shares (the "Programme"), alongside its Full Year 2021 results. The Programme will commence on 14 February 2022 and will end no later than 31 December 2022.

 

The purpose of the Programme is to reduce the issued share capital of the Company. The purchased shares will be held in Treasury. The Company has entered into an agreement with UBS AG ("UBS") to enable the purchase of Ordinary Shares for the initial stage of the Programme.

 

The number of ordinary shares permitted to be purchased by the Company, pursuant to the authority granted by the shareholders at the annual general meeting of the Company on 28 April 2021 (the "2021 AGM"), is 229,400,000 ordinary shares. Per our AGM authority, the Programme will be carried out on Recognised Investment Exchanges.

 

Any purchases of ordinary shares by the Company in relation to this announcement will be conducted in accordance with the Company's general authority to repurchase shares granted by its shareholders at the Company's 2021 AGM and any further approvals to repurchase shares as may be granted by its shareholders from time to time, the Market Abuse Regulation 596/2014 as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended) and Chapter 12 of the Listing Rules and will be discontinued in the event the Company ceases to have the necessary general authority to repurchase ordinary shares.

 

Enquiries:

 

Investor Relations

British American Tobacco Investor Relations

Mike Nightingale / Victoria Buxton / William Houston / John Harney

+44 (0) 20 7845 1180 / 2012 / 1138 / 1263 

 

British American Tobacco Press Office
+44 (0) 20 7845 2888 (24 hours) | @BATplc 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFTFLIILIF
UK 100

Latest directors dealings